|
Sex
|
|
Female
|
1579
|
41.5
|
|
Male
|
2222
|
58.5
|
|
Age, median (IQR) [range]
|
65 (54–74), [18–95]
|
|
Comorbidities
|
|
Chronic cardiopathy
|
1146
|
30.1
|
|
Chronic pulmonary disease
|
614
|
16.2
|
|
Diabetes mellitus
|
620
|
16.3
|
|
Liver disease
|
167
|
4.4
|
|
Obesity
|
345
|
9.1
|
|
Renal impairment
|
325
|
8.6
|
|
Smoking history
|
477
|
12.5
|
|
No risk factor identified
|
1463
|
38.5
|
|
Baseline hematological malignancies
|
|
Acute lymphoid leukemia
|
169
|
4.4
|
|
Chronic lymphoid leukemia
|
474
|
12.5
|
|
Acute myeloid leukemia
|
497
|
13.1
|
|
Chronic myeloid leukemia
|
161
|
4.2
|
|
Myelodysplastic syndrome
|
279
|
7.3
|
|
Low-intermediate risk
|
138
|
3.6
|
|
High risk
|
48
|
1.3
|
|
Not stated
|
93
|
2.4
|
|
Hairy cell leukemia
|
23
|
0.6
|
|
Hodgkin lymphoma
|
135
|
3.6
|
|
Non-Hodgkin lymphoma
|
1084
|
28.5
|
|
Indolent
|
497
|
13.1
|
|
Aggressive
|
516
|
13.6
|
|
Not stated
|
71
|
1.9
|
|
Essential thrombocythemia
|
69
|
1.8
|
|
Myelofibrosis
|
122
|
3.2
|
|
Polycythemia vera
|
70
|
1.8
|
|
Systemic mastocytosis
|
6
|
0.2
|
|
Multiple myeloma
|
684
|
18.0
|
|
Amyloidosis
|
8
|
0.2
|
|
Aplastic anemia
|
20
|
0.5
|
|
Statusa
|
|
Controlled disease
|
1760
|
46.3
|
|
Complete remission
|
1170
|
30.8
|
|
Partial remission
|
590
|
15.5
|
|
Active
disease
|
1963
|
51.6
|
|
Onset
|
888
|
23.4
|
|
Refractory/Resistant
|
473
|
12.4
|
|
Stable disease
|
524
|
13.8
|
|
Unknown
|
78
|
2.1
|
|
Unknown
|
78
|
2.1
|
